← Home / Incannex Healthcare Inc. (IXHL)
Stock Analysis

Incannex Healthcare Inc. (IXHL)

IXHL
IXHL · Healthcare • Drug Manufacturers - Specialty & Generic
3.74 +0.54%
Track IXHL in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IXHL price is:
52W Range Position
6%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-27 01:35 UTC
WOI Investment Thesis
Mixed
Current market structure would strengthen above 4.03. Holding above 3.64 preserves the current price structure.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Strong
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Elevated
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
3.64
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
4.03
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
JUN
10
↺
Share Repurchase
MEDIUM
Incannex Receives A$6.0 Million R&D Tax
Incentive Refund for FY25, Further Strengthening Balance Sheet and Financial Flexibility In addition to the A$6.0 million refund received, the Company expects a further approximately A$5.1 million in R&D Tax Incentive proceeds later this year, bringing total expected non-dilutive funding under the program to more th...
8-K Filing • SEC EDGAR
What's Driving IXHL?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
Below 3.64
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
71.5
◎
How to read this setup
The nearest decision zone is framed by support around 3.64 and resistance near 4.03. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
IXHL — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-26
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$44.9M
Company size
EV
$-29.5M
Debt-adjusted value
P/B
0.7
Low book multiple
P/FCF
-5.4
Not meaningful
FCF Yield
-18.44%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
86,000
↘ Weak
📈 Net Income
-3.88M
↘ Negative
🧮 EPS (Basic)
-0.35
↘ Negative
Incannex Healthcare Inc.
Healthcare • Drug Manufacturers - Specialty & Generic
You Might Also Like